- •Foreword
- •Preface
- •Contents
- •About the Editors
- •Contributors
- •1: Tracheobronchial Anatomy
- •Trachea
- •Introduction
- •External Morphology
- •Internal Morphology
- •Mucous Layer
- •Blood Supply
- •Anatomo-Clinical Relationships
- •Bronchi
- •Main Bronchi
- •Bronchial Division
- •Left Main Bronchus (LMB)
- •Right Main Bronchus (RMB)
- •Blood Supply
- •References
- •2: Flexible Bronchoscopy
- •Introduction
- •History
- •Description
- •Indications and Contraindications
- •Absolute Contraindications
- •Procedure Preparation
- •Technique of FB Procedure
- •Complications of FB Procedure
- •Basic Diagnostic Procedures
- •Bronchoalveolar Lavage (BAL)
- •Transbronchial Lung Biopsy (TBLB)
- •Transbronchial Needle Aspiration (TBNA)
- •Bronchial Brushings
- •Advanced Diagnostic Bronchoscopy
- •EBUS-TBNA
- •Ultrathin Bronchoscopy
- •Transbronchial Lung Cryobiobsy (TBLC)
- •Therapeutic Procedures Via FB
- •LASER Bronchoscopy
- •Electrocautery
- •Argon Plasma Coagulation (APC)
- •Cryotherapy
- •Photodynamic Therapy
- •Airway Stent Placement
- •Endobronchial Valve Placement
- •Conclusion
- •References
- •History and Historical Perspective
- •Indications and Contraindications
- •Procedure Description
- •Procedure Planning
- •Target Approximation
- •Sampling
- •Complications
- •Future Directions
- •Summary and Recommendations
- •References
- •4: Rigid Broncoscopy
- •Innovations
- •Ancillary Equipment
- •Rigid Bronchoscopy Applications
- •Laser Bronchoscopy
- •Tracheobronchial Prosthesis
- •Transbronchial Needle Aspiration (TBNA)
- •Rigid Bronchoscope in Other Treatments for Bronchial Obstruction
- •Mechanical Debridement
- •Pediatric Rigid Bronchoscopy
- •Tracheobronchial Dilatation
- •Foreign Bodies Removal
- •Other Indications
- •Complications
- •The Procedure
- •Some Conclusions
- •References
- •History and Historical Perspective
- •Indications and Contraindications
- •Preprocedural Evaluation and Preparation
- •Physical Examination
- •Procedure-Related Indications
- •Application of the Technique
- •Topical Anesthesia
- •Anesthesia of the Nasal Mucosa and Nasopharynx
- •Anesthesia of the Mouth and Oropharynx
- •Superior Laryngeal Nerve Block
- •Recurrent Laryngeal Nerve Block (RLN)
- •Conscious Sedation
- •Monitored Anesthesia Care (MAC)
- •General Anesthesia
- •Monitoring the Depth of Anesthesia
- •Interventional Bronchoscopy Suites
- •Airway Devices
- •Laryngeal Mask Airway (LMA)
- •Endotracheal Tube (ETT)
- •Rigid Bronchoscope
- •Modes of Ventilation
- •Spontaneous Ventilation
- •Assisted Ventilation
- •Noninvasive Positive Pressure Ventilation (NIV)
- •Positive Pressure Controlled Mechanical Ventilation
- •Jet Ventilation
- •Electronic Mechanical Jet Ventilation
- •Postprocedure Care
- •Special Consideration
- •Anesthesia for Peripheral Diagnostic and Therapeutic Bronchoscopy
- •Anesthesia for Interventional Bronchoscopic Procedures During the COVID-19 Pandemic
- •Summary and Recommendations
- •Conclusion
- •References
- •Background
- •Curricular Structure and Delivery
- •What Is a Bronchoscopy Curriculum?
- •Tradition, Teaching Styles, and Beliefs
- •Using Assessment Tools to Guide the Educational Process
- •The Ethics of Teaching
- •When Learners Teach: The Journey from Novice to Mastery and Back Again
- •The Future Is Now
- •References
- •Interventional Procedure
- •Assessment of Flow–Volume Curve
- •Dyspnea
- •Analysis of Pressure–Pressure Curve
- •Conclusions
- •References
- •Introduction
- •Adaptations of the IP Department
- •Environmental Control
- •Personal Protective Equipment
- •Procedure Performance
- •Bronchoscopy in Intubated Patients
- •Other Procedures in IP Unit
- •References
- •Introduction
- •Safety
- •Patient Safety
- •Provider Safety
- •Patient Selection and Screening
- •Lung Cancer Diagnosis and Staging
- •Inpatients
- •COVID-19 Clearance
- •COVID Clearance: A Role for Bronchoscopy
- •Long COVID: A Role for Bronchoscopy
- •Preparing for the Next Pandemic
- •References
- •Historical Perspective
- •Indications and Contraindications
- •Evidence-Based Review
- •Summary and Recommendations
- •References
- •Introduction
- •Clinical Presentation
- •Diagnosis
- •Treatment
- •History and Historical Perspectives
- •Indications and Contraindications
- •Benign and Malignant Tumors
- •Tumors with Uncertain Prognosis
- •Application of the Technique
- •Evidence Based Review
- •Summary and Recommendations
- •References
- •12: Cryotherapy and Cryospray
- •Introduction
- •Historical Perspective
- •Equipment
- •Cryoadhesion
- •Indications
- •Cryorecanalization
- •Cryoadhesion and Foreign Body Removal
- •Cryoadhesion and Mucus Plugs/Blood Clot Retrieval
- •Endobronchial Cryobiopsy
- •Transbronchial Cryobiopsy for Lung Cancer
- •Safety Concerns and Contraindications
- •Cryoablation
- •Indications
- •Evidence
- •Safety Concerns and Contraindications
- •Cryospray
- •Indications
- •Evidence
- •Safety Concerns and Contraindications
- •Advantages of Cryotherapy
- •Limitations
- •Future Research Directions
- •References
- •13: Brachytherapy
- •History and Historical Perspective
- •Indications and Contraindications
- •Application of the Technique
- •Evidence-Based Review
- •Adjuvant Treatment
- •Palliative Treatment
- •Complications
- •Summary and Recommendations
- •References
- •14: Photodynamic Therapy
- •Introduction
- •Photosensitizers
- •First-Generation Photosensitizers
- •M-Tetrahidroxofenil Cloro (mTHPC) (Foscan®)
- •PDT Reaction
- •Tumor Damage Process
- •Procedure
- •Indications
- •Curative PDT Indications
- •Palliative PDT Indications
- •Contraindications
- •Rationale for Use in Early-Stage Lung Cancer
- •Rationale
- •PDT in Combination with Other Techniques for Advanced-Stage Non-small Cell Lung Cancer
- •Commentary
- •Complementary Endoscopic Methods for PDT Applications
- •New Perspectives
- •Other PDT Applications
- •Conclusions
- •References
- •15: Benign Airways Stenosis
- •Etiology
- •Congenital Tracheal Stenosis
- •Iatrogenic
- •Infectious
- •Idiopathic Tracheal Stenosis
- •Distal Bronchial Stenosis
- •Diagnosis Methods
- •Patient History
- •Imaging Techniques
- •Bronchoscopy
- •Pulmonary Function Test
- •Treatment
- •Endoscopic Treatment
- •Dilatation
- •Laser Therapy
- •Stents
- •How to Proceed
- •Stent Placement
- •Placing a Montgomery T Tube
- •The Rule of Twos for Benign Tracheal Stenosis (Fig. 15.23)
- •Surgery
- •Summary and Recommendations
- •References
- •16: Endobronchial Prostheses
- •Introduction
- •Indications
- •Extrinsic Compression
- •Intraluminal Obstruction
- •Stump Fistulas
- •Esophago-respiratory Fistulas (ERF)
- •Expiratory Central Airway Collapse
- •Physiologic Rationale for Airway Stent Insertion
- •Stent Selection Criteria
- •Stent-Related Complications
- •Granulation Tissue
- •Stent Fracture
- •Migration
- •Contraindications
- •Follow-Up and Patient Education
- •References
- •Introduction
- •Overdiagnosis
- •False Positives
- •Radiation
- •Risk of Complications
- •Lung Cancer Screening Around the World
- •Incidental Lung Nodules
- •Management of Lung Nodules
- •References
- •Introduction
- •Minimally Invasive Procedures
- •Mediastinoscopy
- •CT-Guided Transthoracic Biopsy
- •Fluoroscopy-Guided Transthoracic Biopsies
- •US-Guided Transthoracic Biopsy
- •Thoracentesis and Pleural Biopsy
- •Thoracentesis
- •Pleural Biopsy
- •Surgical or Medical Thoracoscopy
- •Image-Guided Pleural Biopsy
- •Closed Pleural Biopsy
- •Image-Guided Biopsies for Extrathoracic Metastases
- •Tissue Acquisition, Handling and Processing
- •Implications of Tissue Acquisition
- •Guideline Recommendations for Tissue Acquisition in Mediastinal Staging
- •Methods to Overcome Challenges in Tissue Acquisition and Genotyping
- •Rapid on-Site Evaluation (ROSE)
- •Sensitive Genotyping Assays
- •Liquid Biopsy
- •Summary, Recommendations and Highlights
- •References
- •History
- •Data Source and Methodology
- •Tumor Size
- •Involvement of the Main Bronchus
- •Atelectasis/Pneumonitis
- •Nodal Staging
- •Proposal for the Revision of Stage Groupings
- •Small Cell Lung Cancer (SCLC)
- •Discussion
- •Methodology
- •T Descriptors
- •N Descriptors
- •M Descriptors
- •Summary
- •References
- •Introduction
- •Historical Perspective
- •Fluoroscopy
- •Radial EBUS Mini Probe (rEBUS)
- •Ultrasound Bronchoscope (EBUS)
- •Virtual Bronchoscopy
- •Trans-Parenchymal Access
- •Cone Beam CT (CBCT)
- •Lung Vision
- •Sampling Instruments
- •Conclusions
- •References
- •History and Historical Perspective
- •Narrow Band Imaging (NBI)
- •Dual Red Imaging (DRI)
- •Endobronchial Ultrasound (EBUS)
- •Optical Coherence Tomography (OCT)
- •Indications and Contraindications
- •Confocal Laser Endomicroscopy and Endocytoscopy
- •Raman Spectrophotometry
- •Application of the Technique
- •Supplemental Technology for Diagnostic Bronchoscopy
- •Evidence-Based Review
- •Summary and Recommendations, Highlight of the Developments During the Last Three Years (2013 on)
- •References
- •Introduction
- •History and Historical Perspective
- •Endoscopic AF-OCT System
- •Preclinical Studies
- •Clinical Studies
- •Lung Cancer
- •Asthma
- •Airway and Lumen Calibration
- •Obstructive Sleep Apnea
- •Future Applications
- •Summary
- •References
- •23: Endobronchial Ultrasound
- •History and Historical Perspective
- •Equipment
- •Technique
- •Indication, Application, and Evidence
- •Convex Probe Ultrasound
- •Equipment
- •Technique
- •Indication, Application, and Evidence
- •CP-EBUS for Malignant Mediastinal or Hilar Adenopathy
- •CP-EBUS for the Staging of Non-small Cell Lung Cancer
- •CP-EBUS for Restaging NSCLC After Neoadjuvant Chemotherapy
- •Complications
- •Summary
- •References
- •Introduction
- •What Is Electromagnetic Navigation?
- •SuperDimension Navigation System (EMN-SD)
- •Computerized Tomography
- •Computer Interphase
- •The Edge Catheter: Extended Working Channel (EWC)
- •Procedural Steps
- •Planning
- •Detecting Anatomical Landmarks
- •Pathway Planning
- •Saving the Plan and Exiting
- •Registration
- •Real-Time Navigation
- •SPiN System Veran Medical Technologies (EMN-VM)
- •Procedure
- •Planning
- •Navigation
- •Biopsy
- •Complications
- •Limitations
- •Summary
- •References
- •Introduction
- •Image Acquisition
- •Hardware
- •Practical Considerations
- •Radiation Dose
- •Mobile CT Studies
- •Future Directions
- •Conclusion
- •References
- •26: Robotic Assisted Bronchoscopy
- •Historical Perspective
- •Evidence-Based Review
- •Diagnostic Yield
- •Monarch RAB
- •Ion Endoluminal Robotic System
- •Summary
- •References
- •History and Historical Perspective
- •Indications and Contraindications
- •General
- •Application of the Technique
- •Preoperative Care
- •Patient’s Position and Operative Field
- •Incision and Initial Dissection
- •Palpation
- •Biopsy
- •Control of Haemostasis and Closure
- •Postoperative Care
- •Complications
- •Technical Variants
- •Extended Cervical Mediastinoscopy
- •Mediastinoscopic Biopsy of Scalene Lymph Nodes
- •Inferior Mediastinoscopy
- •Mediastino-Thoracoscopy
- •Video-Assisted Mediastinoscopic Lymphadenectomy
- •Transcervical Extended Mediastinal Lymphadenectomy
- •Evidence-Based Review
- •Summary and Recommendations
- •References
- •Introduction
- •Case 1
- •Adrenal and Hepatic Metastases
- •Brain
- •Bone
- •Case 1 Continued
- •Biomarkers
- •Case 1 Concluded
- •Case 2
- •Chest X-Ray
- •Computerized Tomography
- •Positive Emission Tomography
- •Magnetic Resonance Imaging
- •Endobronchial Ultrasound with Transbronchial Needle Aspiration
- •Transthoracic Needle Aspiration
- •Transbronchial Needle Aspiration
- •Endoscopic Ultrasound with Needle Aspiration
- •Combined EUS-FNA and EBUS-TBNA
- •Case 2 Concluded
- •Case 3
- •Standard Cervical Mediastinoscopy
- •Extended Cervical Mediastinoscopy
- •Anterior Mediastinoscopy
- •Video-Assisted Thoracic Surgery
- •Case 3 Concluded
- •Case 4
- •Summary
- •References
- •29: Pleural Anatomy
- •Pleural Embryonic Development
- •Pleural Histology
- •Cytological Characteristics
- •Mesothelial Cells Functions
- •Pleural Space Defense Mechanism
- •Pleura Macroscopic Anatomy
- •Visceral Pleura (Pleura Visceralis or Pulmonalis)
- •Parietal Pleura (Pleura Parietalis)
- •Costal Parietal Pleura (Costalis)
- •Pleural Cavity (Cavitas Thoracis)
- •Pleural Apex or Superior Pleural Sinus [12–15]
- •Anterior Costal-Phrenic Sinus or Cardio-Phrenic Sinus
- •Posterior Costal-Phrenic Sinus
- •Cost-Diaphragmatic Sinus or Lateral Cost-Phrenic Sinus
- •Fissures18
- •Pleural Vascularization
- •Parietal Pleura Lymphatic Drainage
- •Visceral Pleura Lymphatic Drainage
- •Pleural Innervation
- •References
- •30: Chest Ultrasound
- •Introduction
- •The Technique
- •The Normal Thorax
- •Chest Wall Pathology
- •Pleural Pathology
- •Pleural Thickening
- •Pneumothorax
- •Pulmonary Pathology
- •Extrathoracic Lymph Nodes
- •COVID and Chest Ultrasound
- •Conclusions
- •References
- •Introduction
- •History of Chest Tubes
- •Overview of Chest Tubes
- •Contraindications for Chest Tube Placement
- •Chest Tube Procedural Technique
- •Special Considerations
- •Pneumothorax
- •Empyema
- •Hemothorax
- •Chest Tube Size Considerations
- •Pleural Drainage Systems
- •History of and Introduction to Indwelling Pleural Catheters
- •Indications and Contraindications for IPC Placement
- •Special Considerations
- •Non-expandable Lung
- •Chylothorax
- •Pleurodesis
- •Follow-Up and IPC Removal
- •IPC-Related Complications and Management
- •Competency and Training
- •Summary
- •References
- •32: Empyema Thoracis
- •Historical Perspectives
- •Incidence
- •Epidemiology
- •Pathogenesis
- •Clinical Presentation
- •Radiologic Evaluation
- •Biochemical Analysis
- •Microbiology
- •Non-operative Management
- •Prognostication
- •Surgical Management
- •Survivorship
- •Summary and Recommendations
- •References
- •Evaluation
- •Initial Intervention
- •Pleural Interventions for Recurrent Symptomatic MPE
- •Especial Circumstances
- •References
- •34: Medical Thoracoscopy
- •Introduction
- •Diagnostic Indications for Medical Thoracoscopy
- •Lung Cancer
- •Mesothelioma
- •Other Tumors
- •Tuberculosis
- •Therapeutic Indications
- •Pleurodesis of Pneumothorax
- •Thoracoscopic Drainage
- •Drug Delivery
- •Procedural Safety and Contraindications
- •Equipment
- •Procedure
- •Pre-procedural Preparations and Considerations
- •Procedural Technique [32]
- •Medical Thoracoscopy Versus VATS
- •Conclusion
- •References
- •Historical Perspective
- •Indications and Contraindications
- •Evidence-Based Review
- •Endobronchial Valves
- •Airway Bypass Tracts
- •Coils
- •Other Methods of ELVR
- •Summary and Recommendations
- •References
- •36: Bronchial Thermoplasty
- •Introduction
- •Mechanism of Action
- •Trials
- •Long Term: Ten-Year Study
- •Patient Selection
- •Bronchial Thermoplasty Procedure
- •Equipment
- •Pre-procedure
- •Bronchoscopy
- •Post-procedure
- •Conclusion
- •References
- •Introduction
- •Bronchoalveolar Lavage (BAL)
- •Technical Aspects of BAL Procedure
- •ILD Cell Patterns and Diagnosis from BAL
- •Technical Advises for Conventional TLB and TLB-C in ILD
- •Future Directions
- •References
- •Introduction
- •The Pediatric Airway
- •Advanced Diagnostic Procedures
- •Endobronchial Ultrasound
- •Virtual Navigational Bronchoscopy
- •Cryobiopsy
- •Therapeutic Procedures
- •Dilation Procedures
- •Thermal Techniques
- •Mechanical Debridement
- •Endobronchial Airway Stents
- •Metallic Stents
- •Silastic Stents
- •Novel Stents
- •Endobronchial Valves
- •Bronchial Thermoplasty
- •Discussion
- •References
- •Introduction
- •Etiology
- •Congenital ADF
- •Malignant ADF
- •Cancer Treatment-Related ADF
- •Benign ADF
- •Iatrogenic ADF
- •Diagnosis
- •Treatment Options
- •Endoscopic Techniques
- •Stents
- •Clinical Results
- •Stent Complications
- •Other Available Stents
- •Other Endoscopic Methods
- •References
- •Introduction
- •Anatomy and Physiology of Swallowing
- •Functional Physiology of Swallowing
- •Epidemiology and Risk Factors
- •Types of Foreign Bodies
- •Organic
- •Inorganic
- •Mineral
- •Miscellaneous
- •Clinical Presentation
- •Acute FB
- •Retained FB
- •Radiologic Findings
- •Bronchoscopy
- •Airway Management
- •Rigid Vs. Flexible Bronchoscopy
- •Retrieval Procedure
- •Instruments
- •Grasping Forceps
- •Baskets
- •Balloons
- •Suction Instruments
- •Ablative Therapies
- •Cryotherapy
- •Laser Therapy
- •Electrocautery and APC
- •Surgical Management
- •Complications
- •Bleeding and Hemoptysis
- •Distal Airway Impaction
- •Iron Pill Aspiration
- •Follow-Up and Sequelae
- •Conclusion
- •References
- •Vascular Origin of Hemoptysis
- •History and Historical Perspective
- •Diagnostic Bronchoscopy
- •Therapeutic Bronchoscopy
- •General Measures
- •Therapeutic Bronchoscopy
- •Evidence-Based Review
- •Summary
- •Recommendations
- •References
- •History
- •“The Glottiscope” (1807)
- •“The Esophagoscope” (1895)
- •The Rigid Bronchoscope (1897–)
- •The Flexible Bronchoscope (1968–)
- •Transbronchial Lung Biopsy (1972) (Fig. 42.7)
- •Laser Therapy (1981–)
- •Endobronchial Stents (1990–)
- •Electromagnetic Navigation (2003–)
- •Bronchial Thermoplasty (2006–)
- •Endobronchial Microwave Therapy (2004–)
- •American Association for Bronchology and Interventional Pulmonology (AABIP) and Journal of Bronchology and Interventional Pulmonology (JOBIP) (1992–)
- •References
- •Index
31 Overview of the Spectrum of Chest Tubes with a Focus on Indwelling Pleural Catheters… |
565 |
|
|
Fig. 31.13 Tunnel tract infection
space through the subcutaneous tissue and is an uncommon occurrence seen in less than 5% of patients with IPC [31]. Tract metastasis is most common in patients with mesothelioma but can occur with other malignancies. Diagnosis can be obtained with a biopsy and localized radiation is typically the treatment [31].
Cellulitis and exit-site infections are the most common IPC-related infections, but infections in the pleural space are the most worrisome (Fig. 31.13). Pleural space infections are reported to occur in less than 5% of patients and although outcomes are much better than previously reported, they are associated with a mortality rate of 6% and therefore every effort should be made to prevent this complication [57]. Specifc management recommendations depend on the underlying infection and patient-related factors, but removal of an IPC is often not required [52, 53]. Outpatient antibiotics adequately targeting skin pathogens are generally suffcient to treat cellulitis, exit site, and tunnel tract infections. The suggested duration of treatment ranges from seven to ten days, but longer courses of treatment may be necessary for tunnel tract infections [53]. Fluid cultures should be obtained when a pleural space infection is suspected [52], but further research is necessary to determine the optimal method for obtaining the uid, either from the IPC or a separate thoracentesis procedure. Broad spectrum antimicrobial therapy that includes coverage of anaerobes, Staphylococcus aureus, and gram-negative organisms should be started initially and then narrowed based on culture results and patient clinical status. As with any pleural space infection, continuous pleural drainage is optimal, and intra-pleural fbrinolyt-
ics and DNase can be used in patients with suboptimal drainage or signifcant loculations [52, 53]. Lung decortication or other surgical intervention is typically reserved for those patients not improving with more conservative measures and is not recommended as frst-line therapy [53]. IPC removal and placement of a chest tube may be necessary when a tunnel tract infection is complicating a pleural space infection, if pleural drainage is poor despite fbrinolytic administration and if there is no signifcant clinical improvement despite antibiotics and continuous IPC drainage [52, 53].
Patients treated with chemotherapy do not have a signifcantly increased risk of IPC-related infectious complications based on current evidence; therefore, IPC placement is recommended for palliation of symptoms in this patient population [52, 58].
Competency and Training
Competency with chest tube insertion is important in maximizing procedural success and patient outcomes while minimizing potential complications. According to the BTS guidelines published in 2010, required preprocedural training for chest tube insertion involves a “combination of didactic lectures, simulated practice, and supervised practice” until the achievement of competency [5]. The ACCP suggests 10 procedures are required to achieve basic competency with an additional fve procedures each year to maintain [59]. Despite the small number of required procedures recommended to achieve competency, only 30% of pulmonary medicine fellowship programs in the US and Canada meet all the necessary procedural requirements [60, 61]. An interventional pulmonary (IP) fellowship may help to fll training gaps and provide additional advanced skills not required by the European Respiratory Society, American College of Chest Physicians and American Thoracic Society guidelines for general pulmonary training. According to guidelines published by the multi-society interventional pulmonology fel-
566 |
A. J. Schwalk and A. Rudkovskaia |
|
|
|
|
lowship accreditation committee, a minimum of |
Ultrasound-Guided Thoracentesis Skills and |
|
20 image-guided thoracoscopy tubes and 20 IPC |
Tasks Assessment Test, which consists of |
|
placement procedures must be performed to suc- |
11-domains with a 100-point scoring system and |
|
cessfully complete an IP fellowship [62]. The |
serves as a validated tool for assessing the ade- |
|
number of procedures is used as a general out- |
quacy of thoracic ultrasound [67]. Finally, the |
|
line to standardize training across various IP fel- |
Tool for Assessing Chest Tube Insertion |
|
lowship training programs; however, it is not the |
Competency (TACTIC) was developed and vali- |
|
sole criterion that guarantees competency |
dated to assess pediatric emergency medicine |
|
achievement. |
practitioner’s skills and consists of 20 items with |
|
Trainees enter fellowship with various skill- |
a 40-point scoring system. |
|
sets and learning styles, which requires an indi- |
We recommend an individualized and multi- |
|
vidualized approach to training and competency |
faceted approach to procedural training and com- |
|
assessment. Due to the need for a personalized |
petency assessment frst utilizing all available |
|
approach, the traditional apprenticeship training, |
study and simulation materials followed by |
|
where trainees are expected to imitate skills of |
supervised practice. It is recommended that train- |
|
experienced operators on live patients, is no lon- |
ees progress from observing to assisting and later |
|
ger acceptable in the early stages of training. |
to placing chest tubes under supervision. |
|
Studies have shown that the participation of |
Continued assessment of procedural skills and |
|
trainees in procedures not only increases proce- |
outcome analyses during fellowship is essential |
|
dure time and the number of sedative medica- |
to ensure trainee competency and confdence |
|
tions used, but may also result in a higher rate of |
prior to graduation and the start of independent |
|
complications [63]. One proposed methodology |
practice. |
|
for advanced procedural training recommends |
|
|
organization into fve stages: (1) theoretical lec- |
|
|
Summary |
||
tures, recorded videos, and manuals with an |
||
emphasis on problem-based learning, (2) practi- |
|
|
cal application using low and high-fdelity simu- |
Chest tubes are utilized for the treatment of a |
|
lators, cadavers, and animal models, (3) |
multitude of pleural diseases with increasing data |
|
supervised sessions on patients, (4) assessment of |
to support the use of small-bore chest tubes over |
|
competency using various assessment tools, and |
larger ones for many of these conditions. |
|
(5) continuous professional development and |
Indwelling pleural catheters are being placed |
|
maintenance of skills [64]. |
with increasing frequency for both malignant and |
|
There are various approaches to qualitative |
non-malignant pleural effusions and can contrib- |
|
competency assessment, including case-based |
ute to signifcant improvement in patient symp- |
|
questionnaires, evaluation of appropriate |
toms. An ever-expanding amount of research |
|
decision-making, management of complications, |
pertaining to IPC use is now available including |
|
and assessment of maneuvers on mannequins and |
guidelines and expert panel recommendations for |
|
patients under direct supervision. TUBE- |
post-insertion management and treatment of |
|
iCOMPT and UGSTAT have been developed in |
complications. Available data is expected to |
|
line with BTS guidelines and international con- |
increase over time and remaining educated |
|
sensus. TUBE-iCOMPT (Chest Tube Insertion |
regarding this new information is crucial for opti- |
|
Competency Test) is a validated chest tube inser- |
mal patient outcomes. Patient safety is of utmost |
|
tion procedural assessment tool consisting of fve |
importance when performing any procedure, |
|
assessment domains, four of which are applicable |
including chest tube and IPC placement; there- |
|
to evaluate Seldinger technique and four to assess |
fore, validated tools and guidelines have been |
|
knowledge of blunt dissection method, with a |
established to standardize training and compe- |
|
fnal score of 100 points [65, 66]. UGSTAT is the |
tency in pleural procedures. |
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
31 Overview of the Spectrum of Chest Tubes with a Focus on Indwelling Pleural Catheters… |
567 |
|
|
References
1.\Hippocrates. Potter P t. Hippocrates, vol. VI. Cambridge (MA): Harvard University Press; 1988. p. 39–43.
2.\Churchill ED. Wound surgery encounters dilemma. J Thorac Surg. 1958;35:279–90.
3.\Playfair GE. Case of empyema treated by aspiration and subsequently by drainage: recovery. Br Med J. 1875;1:45.
4.\Maloney JVJ. The conservative management of traumatic hemothorax. Am J Surg. 1957;93:533–9.
5.\Havelock T, Teoh R, Laws D, Gleeson F, Group BTSPDG. Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65 Suppl 2:61–76.
6.\Corcoran JP, Psallidas I, Wrightson JM, Hallifax RJ, Rahman NM. Pleural procedural complications: prevention and management. J Thorac Dis. 2015;7(6):1058–67.
7.\Collop NA, Kim S, Sahn SA. Analysis of tube thoracostomy performed by pulmonologists at a teaching hospital. Chest. 1997;112(3):709–13.
8.\Baumann MH, Strange C, Heffner JE, Light RW, Kirby TJ, Klein J, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi Consensus Statement. Chest. 2001;119(2):590–602.
9.\Light RW. Pneumothorax. In: Light RW, editor. Pleural diseases. 6th ed. Philadelphia; 2013.
10.\Hallifax RJ, McKeown E, Sivakumar P, Fairbairn I, Peter C, Leitch A, et al. Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial. Lancet. 2020;396(10243):39–49.
11.\Thethi I, Ramirez S, Shen W, Zhang D, Mohamad M, Kaphle U, et al. Effect of chest tube size on pleurodesis effcacy in malignant pleural effusion: a meta- analysis of randomized controlled trials. J Thorac Dis. 2018;10(1):355–62.
12.\Kheir F, Thakore S, Mehta H, Jantz M, Parikh M, Chee A, et al. Intrapleural fbrinolytic therapy versus early Medical thoracoscopy for treatment of pleural infection. Randomized controlled clinical trial. Ann Am Thorac Soc. 2020;17(8):958–64.
13.\Bauman ZM, Kulvatunyou N, Joseph B, Gries L, O'Keeffe T, Tang AL, et al. Randomized clinical trial of 14-French (14F) pigtail catheters versus 28-32F chest tubes in the Management of Patients with traumatic hemothorax and hemopneumothorax. World J Surg. 2021;45(3):880–6.
14.\Bauman ZM, Kulvatunyou N, Joseph B, Jain A, Friese RS, Gries L, et al. A prospective study of 7-year experience using percutaneous 14-French pigtail catheters for traumatic hemothorax/hemopneumothorax at a Level-1 trauma center: size still does not matter. World J Surg. 2018;42(1):107–13.
15.\Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ, Group BTSPDG. Management of a malig-
nant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65 Suppl 2:32–40.
16.\Antony V, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, et al. Management of Malignant Pleural Effusions. Am J Respir Crit Care Med. 2000;162:1987–2001.
17.\Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur Respir J. 2018;52(1):1800349.
18.\Rahman NM, Pepperell J, Rehal S, Saba T, Tang A, Ali N, et al. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis effcacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial. JAMA. 2015;314(24):2641–53.
19.\Chang SH, Kang YN, Chiu HY, Chiu YH. A systematic review and meta-analysis comparing pigtail catheter and chest tube as the initial treatment for pneumothorax. Chest. 2018;153(5):1201–12.
20.\Rahman NM, Maskell NA, Davies CW, Hedley EL, Nunn AJ, Gleeson FV, et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest. 2010;137(3):536–43.
21.\Anegg U, Lindenmann J, Matzi V, Mujkic D, Maier A, Fritz L, et al. AIRFIX: the frst digital postoperative chest tube air owmetry--a novel method to quantify air leakage after lung resection. Eur J Cardiothorac Surg. 2006;29(6):867–72.
22.\Dernevik L, Belboul A, Radberg G. Initial experience with the world’s frst digital drainage system. The benefts of recording air leaks with graphic representation. Eur J Cardiothorac Surg. 2007;31(2):209–13.
23.\Wang H, Hu W, Ma L, Zhang Y. Digital chest drainage system versus traditional chest drainage system after pulmonary resection: a systematic review and meta- analysis. J Cardiothorac Surg. 2019;14(1):13.
24.\Light RW. Pleural effusions. Med Clin North Am. 2011;95(6):1055–70.
25.\Koegelenberg CFN, Shaw JA, Irusen EM, Lee YCG. Contemporary best practice in the management of malignant pleural effusion. Ther Adv Respir Dis. 2018;12:1753466618785098.
26.\Feller-Kopman DJ, Reddy CB, DeCamp MM, Diekemper RL, Gould MK, Henry T, et al. Management of Malignant Pleural Effusions. An offcial ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198(7):839–49.
27.\Ost DE, Niu J, Zhao H, Grosu HB, Giordano SH. Quality gaps and comparative effectiveness of management strategies for recurrent malignant pleural effusions. Chest. 2018;153(2):438–52.
28.\Medical M Aspira drainage system clinician product brochure. 2019. Available from: https://www.merit. com/productshome/documents/.
29.\Patient Information - PleurX System: BD; 2021. Available from: https://www.bd.com/en-us/offerings/ capabilities/interventional-specialties/peritoneal-and-
568 |
A. J. Schwalk and A. Rudkovskaia |
|
|
pleural-drainage/about-the-pleurx-drainage-system/ patient-information-pleurx-system
30.\plc. RM. IPC Indwelling Drainage Catheters -
Pleural |
& Peritoneal 2011–2019. Available |
from: |
https://sales.rocketmedical.com/products/ |
indwelling-drainage-catheters
31.\Chalhoub M, Saqib A, Castellano M. Indwelling pleural catheters: complications and management strategies. J Thorac Dis. 2018;10(7):4659–66.
32.\Ost DE, Jimenez CA, Lei X, Cantor SB, Grosu HB, Lazarus DR, et al. Quality-adjusted survival following treatment of malignant pleural effusions with indwelling pleural catheters. Chest. 2014;145(6):1347–56.
33.\Muruganandan S, Azzopardi M, Fitzgerald DB, Shrestha R, Kwan BCH, Lam DCL, et al. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med. 2018;6(9):671–80.
34.\Wahidi MM, Reddy C, Yarmus L, Feller-Kopman D, Musani A, Shepherd RW, et al. Randomized trial of pleural uid drainage frequency in patients with malignant pleural effusions. The ASAP trial. Am J Respir Crit Care Med. 2017;195(8):1050–7.
35.\Davies HE, Mishra EK, Kahan BC, Wrightson JM, Stanton AE, Guhan A, et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012;307(22):2383–9.
36.\Thomas R, Fysh ETH, Smith NA, Lee P, Kwan BCH, Yap E, et al. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial. JAMA. 2017;318(19):1903–12.
37.\Boshuizen RC, Vd Noort V, Burgers JA, Herder GJM, Hashemi SMS, Hiltermann TJN, et al. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Lung Cancer. 2017;108:9–14.
38.\Putnam JB, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999;86:1992–9.
39.\Pien GW, Gant MJ, Washam CL, Sterman DH. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest. 2001;119(6):1641–6.
40.\DeBiasi EM, Pisani MA, Murphy TE, Araujo K, Kookoolis A, Argento AC, et al. Mortality among patients with pleural effusion undergoing thoracentesis. Eur Respir J. 2015;46(2):495–502.
41.\Walker SP, Morley AJ, Stadon L, De Fonseka D, Arnold DT, Medford ARL, et al. Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients. Chest. 2017;151(5):1099–105.
42.\Shojaee S, Rahman N, Haas K, Kern R, Leise M,
Alnijoumi M, et al. Indwelling |
tunneled pleu- |
ral catheters for refractory hepatic |
hydrothorax in |
patients with cirrhosis: a multicenter study. Chest. 2019;155(3):546–53.
43.\Bramley K, DeBiasi E, Puchalski J. Indwelling pleural catheter placement for nonmalignant pleural effusions. Semin Respir Crit Care Med. 2018;39(6):713–9.
44.\Aboudara M, Maldonado F. Indwelling pleural catheters for benign pleural effusions: what is the evidence? Curr Opin Pulm Med. 2019;25(4):369–73.
45.\Majid A, Kheir F, Fashjian M, Chatterji S, Fernandez- Bussy S, Ochoa S, et al. Tunneled pleural catheter placement with and without talc Poudrage for treatment of pleural effusions due to congestive heart failure. Ann Am Thorac Soc. 2016;13(2):212–6.
46.\Potechin R, Amjadi K, Srour N. Indwelling pleural catheters for pleural effusions associated with end- stage renal disease: a case series. Ther Adv Respir Dis. 2015;9(1):22–7.
47.\Jimenez CA, Mhatre AD, Martinez CH, Eapen GA, Onn A, Morice RC. Use of an indwelling pleural catheter for the management of recurrent chylothorax in patients with cancer. Chest. 2007;132(5):1584–90.
48.\DePew ZS, Iqbal S, Mullon JJ, Nichols FC, Maldonado F. The role for tunneled indwelling pleural catheters in patients with persistent benign chylothorax. Am J Med Sci. 2013;346(5):349–52.
49.\Shafq M, Simkovich S, Hossen S, Feller-Kopman DJ. Indwelling pleural catheter drainage strategy for malignant effusion: a cost-effectiveness analysis. Ann Am Thorac Soc. 2020;17(6):746–53.
50.\Bhatnagar R, Keenan EK, Morley AJ, Kahan BC, Stanton AE, Haris M, et al. Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med. 2018;378(14):1313–22.
51.\Bhatnagar R, Zahan-Evans N, Kearney C, Edey AJ, Stadon LJ, Tremblay A, et al. A novel drug-eluting indwelling pleural catheter for the management of malignant effusions. Am J Respir Crit Care Med. 2018;197(1):136–8.
52.\Miller RJ, Chrissian AA, Lee YCG, Rahman NM, Wahidi MM, Tremblay A, et al. AABIP evidence- informed guidelines and expert panel report for the Management of Indwelling Pleural Catheters. J Bronchology Interv Pulmonol. 2020;27(4):229–45.
53.\Gilbert CR, Wahidi MM, Light RW, Rivera MP, Sterman DH, Thomas R, et al. Management of Indwelling Tunneled Pleural Catheters: a modifed Delphi consensus statement. Chest. 2020;158(5):2221–8.
54.\Fortin M, Tremblay A. Pleural controversies: indwelling pleural catheter vs. pleurodesis for malignant pleural effusions. J Thorac Dis. 2015;7(6):1052–7.
55.\Thomas R, Piccolo F, Miller D, MacEachern PR, Chee AC, Huseini T, et al. Intrapleural fbrinolysis for the treatment of indwelling pleural catheter-related symptomatic loculations: a multicenter observational study. Chest. 2015;148(3):746–51.
56.\Vial MR, Ost DE, Eapen GA, Jimenez CA, Morice RC, O'Connell O, et al. Intrapleural fbrinolytic therapy in patients with nondraining indwelling
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
31 Overview of the Spectrum of Chest Tubes with a Focus on Indwelling Pleural Catheters… |
569 |
|
|
pleural catheters. J Bronchology Interv Pulmonol. 2016;23(2):98–105.
57.\Fysh ETH, Tremblay A, Feller-Kopman D, Mishra EK, Slade M, Garske L, et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest. 2013;144(5):1597–602.
58.\Mekhaiel E, Kashyap R, Mullon J, Maldonado F. Infections associated with Tunnelled indwelling pleural catheters in patients undergoing chemotherapy. J Bronchology Interv Pulmonol. 2013;20:299–303.
59.\Ernst A, Silvestri GA, Johnstone D. American College of Chest P. Interventional pulmonary procedures: guidelines from the American College of Chest Physicians. Chest. 2003;123(5):1693–717.
60.\Pastis N, Nietert P, Silvestri G. Variation in training for interventional pulmonary procedures among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest. 2005;127:1614–21.
61.\Stather D, Jarand J, Silvestri G. An evaluation of procedural training in Canadian respirology fellowship programs: program directors' and fellows' perspectives. Can Respir J. 2009;16:55–9.
62.\Mullon JJ, Burkart KM, Silvestri G, Hogarth DK, Almeida F, Berkowitz D, et al. Interventional pulm-
onology fellowship accreditation standards: executive summary of the multisociety interventional pulmonology fellowship accreditation committee. Chest. 2017;151(5):1114–21.
63.\Stather DR, MacEachern P, Chee A, Dumoulin E, Tremblay A. Trainee impact on procedural complications: an analysis of 967 consecutive exible bronchoscopy procedures in an interventional pulmonology practice. Respiration. 2013;85(5):422–8.
64.\Fielding DI, Maldonado F, Murgu S. Achieving competency in bronchoscopy: challenges and opportunities. Respirology. 2014;19(4):472–82.
65.\Salamonsen M, McGrath D, Steiler G, Ware R, Colt H, Fielding D. A new instrument to assess physician skill at thoracic ultrasound, including pleural effusion markup. Chest. 2013;144(3):930–4.
66.\Salamonsen MR, Bashirzadeh F, Ritchie AJ, Ward HE, Fielding DI. A new instrument to assess physician skill at chest tube insertion: the TUBE- iCOMPT. Thorax. 2015;70(2):186–8.
67.\Williamson JP, Twaddell SH, Lee YC, Salamonsen M, Hew M, Fielding D, et al. Thoracic ultrasound recognition of competence: a position paper of the Thoracic Society of Australia and new Zealand. Respirology. 2017;22(2):405–8.